These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 17699325

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
    Jacobsen PK.
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
    Rossing P, Parving HH, de Zeeuw D.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
    [No Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB, Coffman TM.
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [Abstract] [Full Text] [Related]

  • 7. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 16; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 11. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A, Majkowska L.
    Przegl Lek; 2007 Nov 16; 64(2):81-5. PubMed ID: 17892038
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
    Hirsch S.
    Int J Clin Pract; 2010 Sep 16; 64(10):1337-40. PubMed ID: 20716140
    [No Abstract] [Full Text] [Related]

  • 15. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.
    Jimenez J, Safranek S, Viera AJ.
    Am Fam Physician; 2007 Aug 01; 76(3):423-4. PubMed ID: 17708144
    [No Abstract] [Full Text] [Related]

  • 16. Clinical trials in progression of chronic renal failure.
    Striker GE, Klahr S.
    Adv Intern Med; 1997 Aug 01; 42():555-95. PubMed ID: 9048130
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.